CBP Antibody

About the Target

CBP (CREB-binding protein) is a large, multifunctional nuclear transcriptional coactivator that interacts with diverse transcription factors, including CREB, c-Fos, c-Jun, c-Myb, and nuclear receptors, to regulate gene expression. Structurally, CBP contains multiple protein-protein interaction domains-such as KIX (CREB-binding), CH1/CH3 (transcription factor binding), bromodomain (acetyl-lysine recognition), and several transcriptional activation domains (TADs) located in both N- and C-terminal regions-along with intrinsic histone acetyltransferase (HAT) activity that remodels chromatin. Depending on the literature source, CBP may also be discussed as CREB-binding protein and Histone lysine acetyltransferase CREBBP.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CBP across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CBP is commonly interpreted in the context of neuroscience, developmental biology, and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
• links between target behavior and transcriptional or chromatin-state changes

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CBP. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CBP reflect biology rather than handling. When interpreting CBP, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CBP trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.